<DOC>
	<DOCNO>NCT00857571</DOCNO>
	<brief_summary>The study compare plasma concentration PF-02413873 administration several dos suspension tablet</brief_summary>
	<brief_title>A Four-Way Cross-Over Study To Compare The Plasma Concentrations Of PF-02413873 After Oral Administration Of Several Doses As Suspension And As Tablets .</brief_title>
	<detailed_description />
	<criteria>Healthy male female volunteer . Female volunteer nonchildbearing potential Evidence history clinically significant hematological , renal , endocrine , pulmonary , gastrointestinal , cardiovascular , hepatic , psychiatric , neurologic , allergic disease ( include drug allergy , exclude untreated , asymptomatic , seasonal allergy time dose ) . Any condition possibly affect drug absorption ( eg , gastrectomy ) . A positive urine drug screen .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>October 2010</verification_date>
	<keyword>Dose Response Bioavailability Study</keyword>
</DOC>